• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗病毒缩肽didemnin A的晶体结构与分子结构

Crystal and molecular structure of didemnin A, an antiviral depsipeptide.

作者信息

Hossain M B, Van Der Helm D, Antel J, Sheldrick G M, Weinheimer A J, Sanduja S K

机构信息

Department of Chemistry and Biochemistry, University of Oklahoma, Norman, USA.

出版信息

Int J Pept Protein Res. 1996 Jan-Feb;47(1-2):20-7. doi: 10.1111/j.1399-3011.1996.tb00805.x.

DOI:10.1111/j.1399-3011.1996.tb00805.x
PMID:8907495
Abstract

The molecular structure of didemnin A, the parent compound of a series of antiviral cytotoxic depsipeptides extracted from a marine tunicate Trididemnum solidum of the family of Didemnidae, has been determined by single-crystal X-ray diffraction. In the crystal, didemnin A molecules form pseudo-symmetric dimeric pair. The two molecules in the dimer are held together by strong N--H center dot center dot center dot O and N--H center dot center dot center dot N hydrogen bonds. A chloride ion, placed almost symmetrically between the dimeric pair, forms N--H center dot center dot center dot Cl hydrogen bonds (3.19 and 3.23 Angstrom) with both the molecules. The two independent molecules in the structure have closely similar geometry. For each molecule, the 23-membered depsipeptide ring assumes a folded conformation in the shape of a 'bent figure-of-eight' similar to that observed in the didemnin B crystal structure. The major conformational differences in the macrocycle of didemnin A and didemnin B are around the Hip residue. The root mean-square (RMS) difference of 20 of the 23 endocyclic torsion angles for the two structures is less than 10 degrees, while the three bond torsions in the Hip residue vary by about 50 degrees. The macrocycle conformation is stabilized by a transannular N--H center dot center dot center dot O hydrogen bond linking the isostatine amide group with the leucine carbonyl group. The truncated linear chain is folded back toward the macrocyclic ring and is held by a N--H center dot center dot center dot O hydrogen bond between the leucine amide group and Me-Leu carbonyl group. The transannular hydrogen bond in the didemnin A structure (N4--H center dot center dot center dot O3 = 2.83 Angstrom in both molecule a and molecule b) is noticeably stronger than that observed in the didemnin B structure (3.02 Angstrom). The X-ray structure of didemnin A is generally consistent with that obtained by NMR studies. Within the crystal, the molecules are packed in zig-zag chains formed by intermolecular O--H center dot center dot center dot O hydrogen bonds. The crystal structure and packing of didemnin A are quite different from that of the didemnin B structure.

摘要

从Didemnidae科的海洋被囊动物Trididemnum solidum中提取的一系列具有抗病毒细胞毒性的缩肽的母体化合物didemnin A的分子结构,已通过单晶X射线衍射确定。在晶体中,didemnin A分子形成假对称二聚体对。二聚体中的两个分子通过强N--H···O和N--H···N氢键结合在一起。一个氯离子几乎对称地位于二聚体对之间,与两个分子都形成N--H···Cl氢键(3.19和3.23埃)。结构中的两个独立分子具有非常相似的几何形状。对于每个分子,23元缩肽环呈现出类似于在didemnin B晶体结构中观察到的“弯曲8字形”的折叠构象。didemnin A和didemnin B大环的主要构象差异围绕着Hip残基。两种结构的23个内环扭转角中的20个的均方根(RMS)差异小于10度,而Hip残基中的三个键扭转变化约50度。大环构象通过连接异亮氨酸酰胺基团和亮氨酸羰基的跨环N--H···O氢键得以稳定。截短的线性链向大环环回折,并通过亮氨酸酰胺基团和甲基亮氨酸羰基之间的N--H···O氢键固定。didemnin A结构中的跨环氢键(分子a和分子b中的N4--H···O3 = 2.83埃)明显强于在didemnin B结构中观察到的氢键(3.02埃)。didemnin A的X射线结构与通过核磁共振研究获得的结构总体一致。在晶体内,分子通过分子间O--H···O氢键堆积成锯齿链。didemnin A的晶体结构和堆积与didemnin B结构有很大不同。

相似文献

1
Crystal and molecular structure of didemnin A, an antiviral depsipeptide.抗病毒缩肽didemnin A的晶体结构与分子结构
Int J Pept Protein Res. 1996 Jan-Feb;47(1-2):20-7. doi: 10.1111/j.1399-3011.1996.tb00805.x.
2
Crystal and molecular structure of didemnin B, an antiviral and cytotoxic depsipeptide.抗病毒和细胞毒性缩肽双丙肽B的晶体结构与分子结构
Proc Natl Acad Sci U S A. 1988 Jun;85(12):4118-22. doi: 10.1073/pnas.85.12.4118.
3
The cyclic depsipeptide backbone of the didemnins.海兔毒素的环状缩肽主链。
Acta Crystallogr C. 1995 Aug 15;51 ( Pt 8):1609-14. doi: 10.1107/s0108270194013405.
4
Didemnin B. Conformation and dynamics of an antitumour and antiviral depsipeptide studied in solution by 1H and 13C. n.m.r. spectroscopy.
Int J Pept Protein Res. 1989 Dec;34(6):445-54. doi: 10.1111/j.1399-3011.1989.tb01393.x.
5
Unique molecular conformation of aureobasidin A, a highly amide N-methylated cyclic depsipeptide with potent antifungal activity: X-ray crystal structure and molecular modeling studies.金担子素A的独特分子构象:一种具有强效抗真菌活性的高度酰胺N-甲基化环缩肽,X射线晶体结构和分子模拟研究
J Pept Res. 1999 May;53(5):492-500. doi: 10.1034/j.1399-3011.1999.00046.x.
6
Analysis of conformational equilibria in aplidine using selective excitation 2D NMR spectroscopy and molecular mechanics/dynamics calculations.使用选择性激发二维核磁共振光谱和分子力学/动力学计算分析阿普立定中的构象平衡。
J Org Chem. 2003 Dec 12;68(25):9554-62. doi: 10.1021/jo034798r.
7
A Survey of Didemnin Depsipeptide Production in .Didemnin 去苯肽生产综述。
Mar Drugs. 2023 Jan 17;21(2):56. doi: 10.3390/md21020056.
8
Conformational change from antiparallel beta-sheet to alpha-helix in a series of depsipeptide, -(Leu-Leu-Lac)(n)-: syntheses, spectroscopic studies, and crystal structures of Boc-Leu-Lac-OEt and Boc-(Leu-Leu-Lac)(n)-OEt (n = 1, 2).一系列缩肽-(Leu-Leu-Lac)(n)-中从反平行β-折叠到α-螺旋的构象变化:Boc-Leu-Lac-OEt和Boc-(Leu-Leu-Lac)(n)-OEt(n = 1, 2)的合成、光谱研究及晶体结构
Biopolymers. 2008 Apr;89(4):270-83. doi: 10.1002/bip.20904.
9
Crystal and molecular structure of the depsipeptide ionophore hexadecaisoleucinomycin, cyclo-[(D-Ile-L-Lac-L-Ile-D-Hyi)4-] (C80H136N8O24).环肽离子载体十六异亮氨霉素(环 - [(D - 异亮氨酸 - L - 乳酸 - L - 异亮氨酸 - D - 羟基异丁酸)4 - ],化学式为C80H136N8O24)的晶体和分子结构
Biopolymers. 1992 Jul;32(7):819-27. doi: 10.1002/bip.360320710.
10
Total synthesis of a conformationally constrained didemnin B analog.一种构象受限的双溴萘菌素B类似物的全合成。
J Org Chem. 2001 Apr 20;66(8):2734-42. doi: 10.1021/jo001640n.

引用本文的文献

1
Biocompatible strategies for peptide macrocyclisation.用于肽大环化的生物相容性策略。
Chem Sci. 2024 Jan 5;15(7):2300-2322. doi: 10.1039/d3sc05738k. eCollection 2024 Feb 14.
2
Structural rationale for the cross-resistance of tumor cells bearing the A399V variant of elongation factor eEF1A1 to the structurally unrelated didemnin B, ternatin, nannocystin A and ansatrienin B.携带延伸因子eEF1A1的A399V变体的肿瘤细胞对结构不相关的didemnin B、ternatin、nannocystin A和ansatrienin B产生交叉耐药性的结构原理。
J Comput Aided Mol Des. 2017 Oct;31(10):915-928. doi: 10.1007/s10822-017-0066-x. Epub 2017 Sep 12.
3
Synthetic studies of tamandarin B side chain analogues.
塔曼丁 B 侧链类似物的合成研究。
J Org Chem. 2010 May 7;75(9):3027-36. doi: 10.1021/jo100457w.